Historical record - last NADAC effective date: 2/22/2017

Product Information

TRANDOLAPRIL 4 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2521 per EA under NDC 65862016601. Its NADAC has been published 170 times since Nov 28, 2013.

FDA first approved this application on Jun 12, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRANDOLAPRIL 4 MG TABLET

Trandolapril
$0.2521per EA

Strength

4 mg/1

NDC

65862016601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

2/22/2017

Active Ingredients

TRANDOLAPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA078438

FDA Approved

6/12/2007

TE Code

AB

On Market Since

6/12/2007

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for TRANDOLAPRIL 4 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 7.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2521 per EA
All-time high$0.3443 (Jul 16, 2014)
All-time low$0.1672 (Nov 23, 2016)
Median price$0.2673
Average price$0.2662
Largest weekly change+58.8% (Dec 21, 2016)
Weeks tracked170
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-7.6%

Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TRANDOLAPRIL 4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TRANDOLAPRIL 4 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2521 per EA (NDC 65862016601), effective Feb 22, 2017.

How has the price of TRANDOLAPRIL 4 MG TABLET changed over time?

Over the history we have for it, the NADAC for TRANDOLAPRIL 4 MG TABLET has declined 7.6%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TRANDOLAPRIL 4 MG TABLET?

Since Nov 28, 2013, the NADAC for TRANDOLAPRIL 4 MG TABLET has ranged from a low of $0.1672 (Nov 23, 2016) to a high of $0.3443 (Jul 16, 2014), with a median of $0.2673 per EA.

Are there cheaper alternatives to TRANDOLAPRIL 4 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRANDOLAPRIL 4 MG TABLET, is $0.1530 per EA — about 39% below TRANDOLAPRIL 4 MG TABLET.

Who manufactures TRANDOLAPRIL 4 MG TABLET?

TRANDOLAPRIL 4 MG TABLET (NDC 65862016601) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.